TIDMNANO

RNS Number : 7402M

Nanoco Group PLC

17 October 2016

For immediate release 17 October 2016

NANOCO GROUP PLC

("Nanoco" or the "Company" or "Group")

Director Share Purchase

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, received notification today that Dr Christopher Richards, Non-Executive Chairman, purchased 19,833 ordinary shares of GBP0.10 each ("Ordinary Shares") in the Company on 17 October 2016 at a price of 50.42p per Ordinary Share.

Following this transaction, Christopher has a beneficial interest in 118,830 Ordinary Shares (of which 73,120 are held by his wife, Ann Carolyn Richards), representing approximately 0.05 per cent. of the total voting rights in the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 
  1   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------- 
 a)   Name                             Christopher Richards 
---  -------------------------------  ------------------------ 
 2    Reason for the notification 
---  --------------------------------------------------------- 
 a)   Position/status                  Non-Executive Chairman 
---  -------------------------------  ------------------------ 
 b)   Initial notification/Amendment   Initial notification 
---  -------------------------------  ------------------------ 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, 
       auctioneer or auction monitor 
---  --------------------------------------------------------- 
 a)   Name                             Nanoco Group plc 
---  -------------------------------  ------------------------ 
 b)   LEI                              England & Wales Company 
                                        Number: 05067291 
---  -------------------------------  ------------------------ 
 4    Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------- 
 a)   Description of                   Ordinary Shares 
       the financial instrument, 
       type of instrument 
---  -------------------------------  ------------------------ 
      Identification                   NANO 
       code 
                                        ISIN GB00B01JLR99 
---  -------------------------------  ------------------------ 
 b)   Nature of the transaction        Acquisition of Ordinary 
                                        Shares 
---  -------------------------------  ------------------------ 
 c)   Price(s) and volume(s)           Price(s) 50.42p 
                                        Volume(s) 19,833 
---  -------------------------------  ------------------------ 
 d)   Aggregated information           Price(s) 50.42p 
                                        Volume(s) 19,833 
---  -------------------------------  ------------------------ 
 e)   Date of transaction              17 October 2016 
---  -------------------------------  ------------------------ 
 f)   Place of transaction             London Stock Exchange 
---  -------------------------------  ------------------------ 
 

For further information, please contact:

 
 Nanoco 
 Michael Edelman, Chief           Tel: +44 (0) 161 
  Executive Officer                603 7900 
 David Blain, Chief Financial 
  Officer 
 Caroline Watson, Investor        Tel: + 44 (0) 7799 
  Relations Manager                897357 
 cwatson@nanocotechnologies.com 
 
   Peel Hunt 
 Adrian Trimmings / George        Tel: +44 (0) 20 7418 
  Sellar / Alex Lomax              8900 
 
   Buchanan 
 Mark Court / Sophie Cowles       Tel: +44 (0) 20 7466 
  / Stephanie Watson               5000 
 

Notes for editors:

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEALEXFENKFFF

(END) Dow Jones Newswires

October 17, 2016 10:15 ET (14:15 GMT)

Nanoco (LSE:NANO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Nanoco Charts.
Nanoco (LSE:NANO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Nanoco Charts.